{
    "2021-09-23": [
        [
            {
                "time": "",
                "original_text": "刚，刚，复星医药副总裁辞职 董监高成员变化",
                "features": {
                    "keywords": [
                        "复星医药",
                        "副总裁",
                        "辞职",
                        "董监高成员变化"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药：复星医药关于高级管理人员辞职的公告 董监高成员变化",
                "features": {
                    "keywords": [
                        "复星医药",
                        "高级管理人员",
                        "辞职",
                        "公告",
                        "董监高成员变化"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(02196)：Lihui Zhou请辞副总裁职务",
                "features": {
                    "keywords": [
                        "复星医药",
                        "Lihui Zhou",
                        "副总裁",
                        "辞职"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药：副总裁Lihui Zhou辞职",
                "features": {
                    "keywords": [
                        "复星医药",
                        "副总裁",
                        "Lihui Zhou",
                        "辞职"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药：本集团实际对外担保金额约合人民币约209.91亿元 大额借贷担保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "对外担保",
                        "金额",
                        "大额借贷担保"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药：获《药品生产许可证》 可扩大汉曲优产能",
                "features": {
                    "keywords": [
                        "复星医药",
                        "药品生产许可证",
                        "汉曲优",
                        "产能"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(600196.SH)：Lihui Zhou辞任副总裁职务 董监高成员变化",
                "features": {
                    "keywords": [
                        "复星医药",
                        "Lihui Zhou",
                        "副总裁",
                        "辞职",
                        "董监高成员变化"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药(600196.SH)控股子公司获药品生产许可证",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股子公司",
                        "药品生产许可证"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药：为控股子公司复星实业提供4000万欧元担保",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股子公司",
                        "复星实业",
                        "担保"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "复星医药：控股子公司获《药品生产许可证》，生产注射用曲妥珠单抗",
                "features": {
                    "keywords": [
                        "复星医药",
                        "控股子公司",
                        "药品生产许可证",
                        "注射用曲妥珠单抗"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中泰国际：复星医药子公司治疗慢性心力衰竭新药获FDA同意开展临床试验",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "慢性心力衰竭",
                        "新药",
                        "FDA",
                        "临床试验"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中国短期融资券及中期票据信用分析周报",
                "features": {
                    "keywords": [
                        "短期融资券",
                        "中期票据",
                        "信用分析",
                        "周报"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}